Search research articles
Contact Us
Filters
Showing results (61-70 of 122) with videos related to
Page
of 13
Sort By:
Cancer Investigation
|
August 29, 2002
Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer
J Bellmunt, J Cos, R Clèries, et al.
British Journal of Cancer
|
January 17, 2013
Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis
G Procopio, J Bellmunt, J Dutcher, et al.
Medical and Pediatric Oncology
|
January 1, 1994
Late recurrent metastasis in Wilms' tumour
S Gallego-Melcón, J Sánchez de Toledo, D Doste, et al.
Cancer
|
March 5, 1998
Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma
A Ribas, J Albanell, L A Solé-Calvo, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1995
Malignant lymphoproliferative diseases in HIV-seropositive patients. A study of 40 cases at a single institution in Spain
A Ribas, J Bellmunt, J Albanell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2013
Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
J Bellmunt, R Fougeray, J E Rosenberg, et al.
Actas Urologicas Espanolas
|
September 17, 1999
[Extragonadal germ-cell tumors located in the mediastinum]
E Sotelo Burillo, E Martínez Cuenca, J A Lorente Garín, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2011
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
M D Galsky, G J Chen, W K Oh, et al.
Medical Oncology (Northwood, London, England)
|
September 17, 2009
Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
S Negrier, E Jäger, C Porta, et al.
Cancer
|
October 1, 1992
Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy
J Bellmunt, J Albanell, O S Gallego, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 122) with videos related to
Sort By:
Page
of 13
Cancer Investigation
|
August 29, 2002
Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer
J Bellmunt, J Cos, R Clèries, et al.
British Journal of Cancer
|
January 17, 2013
Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis
G Procopio, J Bellmunt, J Dutcher, et al.
Medical and Pediatric Oncology
|
January 1, 1994
Late recurrent metastasis in Wilms' tumour
S Gallego-Melcón, J Sánchez de Toledo, D Doste, et al.
Cancer
|
March 5, 1998
Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma
A Ribas, J Albanell, L A Solé-Calvo, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1995
Malignant lymphoproliferative diseases in HIV-seropositive patients. A study of 40 cases at a single institution in Spain
A Ribas, J Bellmunt, J Albanell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2013
Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
J Bellmunt, R Fougeray, J E Rosenberg, et al.
Actas Urologicas Espanolas
|
September 17, 1999
[Extragonadal germ-cell tumors located in the mediastinum]
E Sotelo Burillo, E Martínez Cuenca, J A Lorente Garín, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2011
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
M D Galsky, G J Chen, W K Oh, et al.
Medical Oncology (Northwood, London, England)
|
September 17, 2009
Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET
S Negrier, E Jäger, C Porta, et al.
Cancer
|
October 1, 1992
Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy
J Bellmunt, J Albanell, O S Gallego, et al.
Page
of 13